Powered by TradingView

Company Profile

Bioporto A/S is an in-vitro diagnostic company. The company provides healthcare professionals in clinical and research settings a range of diagnostic tests and antibodies. Its product portfolio consists of specialized monoclonal antibodies and antibody-based diagnostic assays, used in the treatment of critically ill patients. The company's segments include the NGAL Test, ELISA Human NGAL kits, ELISA Animal NGAL kits, ELISA MBL kits, Antibodies, and Other products and licenses. Bioporto generates majority of its revenues from Antibodies segment.
Key Stats
Website http://www.bioporto.com
Headquarter country Denmark
Employees 25
Market Cap (at close 16-07-2018) DKK 487M
Morningstar Sector
Morningstar Industry
Stock Style
Fiscal Year Ends december
Board of Directors

Copyright Euroinvestor A/S 2018  Disclaimer  |  Cookie- og privatlivspolitik  |  Persondatapolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
17. juli 2018 15:31:05
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180712.1 - EUROWEB4 - 2018-07-17 15:31:05 - 2018-07-17 15:31:05 - 1 - Website: OKAY